CELYAD ONCOLOGY
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CYADY and buy or sell other stocks, ETFs, and their options commission-free!About CYADY
Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology.
CEOMatthew R. Kane, MBA
CEOMatthew R. Kane, MBA
Employees15
Employees15
HeadquartersMont-Saint-Guibert, Walloon Region
HeadquartersMont-Saint-Guibert, Walloon Region
Founded2007
Founded2007
Employees15
Employees15
CYADY Key Statistics
Market cap24.86M
Market cap24.86M
Price-Earnings ratio-0.43
Price-Earnings ratio-0.43
Dividend yield—
Dividend yield—
Average volume6.73K
Average volume6.73K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.07
52 Week high$3.07
52 Week low$0.15
52 Week low$0.15
Stock Snapshot
The current CELYAD ONCOLOGY(CYADY) stock price is $0.60, with a market capitalization of 24.86M. The stock trades at a price-to-earnings (P/E) ratio of -0.43.
During the trading day, CELYAD ONCOLOGY(CYADY) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 6.73K.
The stock's 52-week range extends from a low of $0.15 to a high of $3.07.
The stock's 52-week range extends from a low of $0.15 to a high of $3.07.